These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23376981)

  • 1. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
    Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
    Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
    Goudet P; Murat A; Binquet C; Cardot-Bauters C; Costa A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Delemer B; Beckers A; Bonithon-Kopp C
    World J Surg; 2010 Feb; 34(2):249-55. PubMed ID: 19949948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines.
    Goudet P; Bonithon-Kopp C; Murat A; Ruszniewski P; Niccoli P; Ménégaux F; Chabrier G; Borson-Chazot F; Tabarin A; Bouchard P; Cadiot G; Beckers A; Guilhem I; Chabre O; Caron P; Du Boullay H; Verges B; Cardot-Bauters C
    Eur J Endocrinol; 2011 Jul; 165(1):97-105. PubMed ID: 21551167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
    Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
    Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
    Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
    Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
    Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.
    Gatta-Cherifi B; Chabre O; Murat A; Niccoli P; Cardot-Bauters C; Rohmer V; Young J; Delemer B; Du Boullay H; Verger MF; Kuhn JM; Sadoul JL; Ruszniewski P; Beckers A; Monsaingeon M; Baudin E; Goudet P; Tabarin A
    Eur J Endocrinol; 2012 Feb; 166(2):269-79. PubMed ID: 22084155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the Danish families with multiple endocrine neoplasia type 1.
    Jäger AC; Friis-Hansen L; Hansen TV; Eskildsen PC; Sølling K; Knigge U; Hansen CP; Andersen PH; Brixen K; Feldt-Rasmussen U; Kroustrup JP; Mollerup CL; Rehfeld JF; Blichert-Toft M; Nielsen FC
    Mol Cell Endocrinol; 2006 Apr; 249(1-2):123-32. PubMed ID: 16563611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
    Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
    Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
    Perakakis N; Flohr F; Kayser G; Thomusch O; Parsons L; Billmann F; von Dobschuetz E; Rondot S; Seufert J; Laubner K
    Hormones (Athens); 2016; 15(1):113-7. PubMed ID: 26732163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple endocrine neoplasia type 1 variants and phenocopies].
    Mamedova EO; Mokrysheva NG; Przhiialkovskaia EG; Pigarova EA; Rozhinskaia LIa; Tiul'pakov AN
    Ter Arkh; 2014; 86(10):87-91. PubMed ID: 25509899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 1: from bedside to benchside.
    Yoshimoto K
    J Med Invest; 2000 Aug; 47(3-4):108-17. PubMed ID: 11019489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.
    Goudet P; Dalac A; Le Bras M; Cardot-Bauters C; Niccoli P; Lévy-Bohbot N; du Boullay H; Bertagna X; Ruszniewski P; Borson-Chazot F; Vergès B; Sadoul JL; Ménégaux F; Tabarin A; Kühn JM; d'Anella P; Chabre O; Christin-Maitre S; Cadiot G; Binquet C; Delemer B
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1568-77. PubMed ID: 25594862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
    Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
    Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.